Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.20 (
alpha-glucosidase
)
4,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
13C-labeled glycosyl ureides were recently proposed as a new marker of the orocecal transit time: after passing the small bowel the sugar-urea bond is split by bacterial
allantoicase
. Further degradation results in 13CO2 which can be measured in the exhaled breath. The aim of this study was to detect an eventual
allantoicase
-like activity in the human gut and to elucidate the metabolism of glycosyl ureides by human intestinal brush border enzymes. Biopsies of 15 duodenal specimen and 6 colon specimen were homogenised and incubated with several disaccharides and their corresponding disaccharide ureides under various experimental conditions. Hydrolysis of the sugar-urea bond could not be observed neither in the small bowel nor in the colon. However, the conjugation between the two sugars was split. In a modified Dahlqvist assay lactase showed the same kinetics with lactose and lactose ureide as substrates whereas maltose showed a significantly 2.6-fold higher affinity to
maltase
than maltose ureide (P < 0.001). No major difference between these two substrates could be detected when total
maltase
activity was inhibited by acarbose. In summary, the human gut tissue possesses no
allantoicase
-like activity. Therefore, glycosyl ureides seem to be appropriate substances to test the orocecal transit time.
...
PMID:Metabolism of glycosyl ureides by human intestinal brush border enzymes. 930